ConductScience.org, home

Paper39755677

Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease.

Di Menna L and 31 others. NPJ Parkinsons Dis, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease. Papers, record 39755677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39755677

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease.
PubMed
Journal
NPJ Parkinsons Dis
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.49, provisional
iCite
Revised in PubMed
2025-01-07
PubMed

Authors32

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Di Menna LLuisa
2Alborghetti MMarikahttps://orcid.org/0000-0001-9327-6660
3De Bartolo MIMaria Ilenia
4Borro MMarina
5Gentile GGiovanna
6Zinni MManuela
7Bologna MMatteo
8Cutrona CCarolina
9D'Errico GGiovanna
10Imbriglio TTiziana
11Bucci DDomenico
12Merlo SSara
13Ginerete RPRoxana Paula
14Orlando RRosamaria
15Carrillo FFederica
16Fortunato GGiorgio
17Cannella MMilena
18Sortino MAMaria Angela
19Pansiot JJulien
20Baud OOlivier

Source PubMed

See all 32 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants19

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
RF-2018-123-68289Ministero della Salute (Ministry of Health, Italy)PubMed
E64117000190001Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research)PubMed
E64117000190001Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research)PubMed
E64117000190001Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research)PubMed
E64117000190001Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research)PubMed
E64117000190001Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research)PubMed

Source PubMed

Download CSV of grants

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121705423Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.Brain2011https://conductscience.org/library/papers/21705423PubMed
218361474The evolution of disability in Parkinson disease.Mov Disord2008https://conductscience.org/library/papers/18361474PubMed
319410592Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.Physiol Behav2009https://conductscience.org/library/papers/19410592PubMed
430687016Idebenone Alleviates Neuroinflammation and Modulates Microglial Polarization in LPS-Stimulated BV2 Cells and MPTP-Induced Parkinson's Disease Mice.Front Cell Neurosci2018https://conductscience.org/library/papers/30687016PubMed
535218231A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease.Mov Disord2022https://conductscience.org/library/papers/35218231PubMed
616720584SNPStats: a web tool for the analysis of association studies.Bioinformatics2006https://conductscience.org/library/papers/16720584PubMed
76607092Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey.Brain Res1984https://conductscience.org/library/papers/6607092PubMed
83430576The efficiency of systematic sampling in stereology and its prediction.J Microsc1987https://conductscience.org/library/papers/3430576PubMed
925792075Are studies of motor cortex plasticity relevant in human patients with Parkinson's disease?Clin Neurophysiol2016https://conductscience.org/library/papers/25792075PubMed
1026237365Dynamic rewiring of neural circuits in the motor cortex in mouse models of Parkinson's disease.Nat Neurosci2015https://conductscience.org/library/papers/26237365PubMed
1121159998
Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
Mol Pharmacol2011https://conductscience.org/library/papers/21159998PubMed
1214749427Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.J Neurosci2004https://conductscience.org/library/papers/14749427PubMed
1310066254Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons but requires transforming growth factor-beta as cofactor in vivo.J Neurosci1999https://conductscience.org/library/papers/10066254PubMed
1426500044Chronic and progressive Parkinson's disease MPTP model in adult and aged mice.J Neurochem2016https://conductscience.org/library/papers/26500044PubMed
1521036182Metabotropic glutamate receptors: from the workbench to the bedside.Neuropharmacology2011https://conductscience.org/library/papers/21036182PubMed
1618256595Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.Neuropsychopharmacology2008https://conductscience.org/library/papers/18256595PubMed
1727296644The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia.Curr Neuropharmacol2016https://conductscience.org/library/papers/27296644PubMed
1819672295Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons.PLoS One2009https://conductscience.org/library/papers/19672295PubMed
1929901693Neurophysiological correlates of bradykinesia in Parkinson's disease.Brain2018https://conductscience.org/library/papers/29901693PubMed
2033037859The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes.Mov Disord2021https://conductscience.org/library/papers/33037859PubMed

See all 64 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42350763Targeting GPCR Signaling in Parkinson's Disease: From Molecular Pathology to Exercise-Based Therapeutics.Mol Neurobiol2026https://conductscience.org/library/papers/42350763PubMed
42305118Decoding GPCR signaling in living cells to advance early therapeutic discovery for neurological disorders.Front Mol Neurosci2026https://conductscience.org/library/papers/42305118PubMed
41904982Neurotransmitter Dysregulation in Parkinson's Disease: Pathophysiological Insights and Therapeutic Perspectives.ACS Chem Neurosci2026https://conductscience.org/library/papers/41904982PubMed
41073451Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease.NPJ Parkinsons Dis2025https://conductscience.org/library/papers/41073451PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GRM32913PubTator's text mininghttps://conductscience.org/library/genes/2913

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39755677

GET https://conductscience.org/api/papers/v1/39755677/authors?page=2